GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cipla Ltd CIPLA.NS · INR

Pharmaceuticals · NSE · 🇮🇳 India

Nifty 50

Compare

1,403.80

-0.51%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹281.63bn

FY2017FY2026

Net income

₹38.79bn

FY2017FY2026

Free cash flow

₹25.27bn

FY2017FY2026

Shareholders' equity

₹344.32bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹281.63bn₹272.67bn₹255.37bn₹225.59bn₹217.08bn₹191.21bn₹170.81bn₹163.23bn₹151.05bn₹143.34bn
Gross profit₹120.36bn₹180.92bn₹164.93bn₹141.04bn₹130.18bn₹116.14bn₹109.32bn₹103.95bn₹95.88bn₹91.13bn
Research and development₹5.21bn₹14.85bn₹15.23bn₹12.93bn₹2.66bn₹1.33bn₹3.56bn₹3.60bn₹2.70bn₹2.81bn
Operating income₹52.70bn₹105.63bn₹94.80bn₹77.96bn₹80.85bn₹73.53bn₹67.07bn₹62.93bn₹59.03bn₹55.31bn
Net income₹38.79bn₹52.73bn₹41.22bn₹28.02bn₹25.17bn₹24.05bn₹15.47bn₹15.28bn₹14.11bn₹10.06bn
Diluted earnings per share47.9865.2250.9934.6831.1729.7719.1418.9317.4912.49

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹424.96bn₹373.87bn₹327.18bn₹294.63bn₹271.01bn₹251.52bn₹236.63bn₹239.63bn₹228.61bn₹210.37bn
Cash and short-term investments₹100.28bn₹106.17bn₹77.96bn₹62.77bn₹46.32bn₹37.46bn₹20.09bn₹27.35bn₹20.58bn₹14.80bn
Total liabilities₹79.76bn₹60.98bn₹59.15bn₹57.50bn₹59.84bn₹65.66bn₹76.05bn₹86.19bn₹82.79bn₹80.55bn
Debt—₹4.38bn₹5.59bn₹8.03bn₹10.56bn₹20.14bn₹30.89bn₹43.16bn₹40.98bn₹41.13bn
Shareholders' equity₹344.32bn₹311.93bn₹267.07bn₹234.08bn₹208.42bn₹183.27bn₹157.63bn₹150.12bn₹142.29bn₹125.44bn
Shares outstanding808m808m808m808m807m808m808m807m806m806m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹41.26bn₹50.05bn₹41.34bn₹32.38bn₹33.26bn₹37.55bn₹30.68bn₹16.91bn₹14.63bn₹23.82bn
Capital spending−₹15.99bn−₹11.62bn−₹13.49bn−₹11.83bn−₹7.01bn−₹8.19bn−₹10.00bn−₹5.27bn−₹8.16bn−₹11.36bn
Free cash flow₹25.27bn₹38.43bn₹27.85bn₹20.55bn₹26.25bn₹29.36bn₹20.68bn₹11.64bn₹6.47bn₹12.46bn
Dividends paid−₹12.92bn−₹10.50bn−₹6.86bn−₹4.04bn−₹4.03bn−₹360.0m−₹5.64bn−₹2.42bn−₹1.61bn−₹1.61bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹70.77bn₹65.41bn₹69.63bn₹75.89bn₹69.57bn₹67.20bn₹69.62bn₹69.61bn
Gross profit₹44.10bn₹24.95bn₹43.31bn₹34.80bn₹32.22bn₹42.84bn₹46.98bn₹46.78bn
Operating income₹8.88bn₹6.14bn₹9.77bn₹15.98bn₹15.39bn₹2.93bn₹35.00bn₹34.70bn
Net income₹7.89bn₹5.55bn₹6.76bn₹13.51bn₹12.98bn₹12.22bn₹15.71bn₹13.03bn
Diluted earnings per share9.766.868.3616.7116.0515.1119.4316.11
Cash from operations———₹13.45bn—₹50.05bn—₹20.55bn
Capital spending———−₹6.65bn—−₹15.48bn—−₹8.14bn
Free cash flow———₹6.80bn—₹34.57bn—₹12.41bn
Total assets—₹424.96bn—₹401.64bn—₹373.87bn—₹346.55bn
Cash and short-term investments₹100.28bn₹100.28bn₹106.02bn₹83.35bn₹106.17bn₹106.17bn₹87.08bn₹87.08bn
Debt—₹3.49bn—₹4.67bn—₹4.39bn—₹4.61bn
Shareholders' equity₹345.20bn₹344.32bn₹330.25bn₹329.19bn₹312.89bn₹311.93bn₹284.56bn₹283.62bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue7.7%8.1%7.6%
Operating income-12.2%-6.4%-0.2%
Net income11.5%10.0%11.1%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin54.4%58.7%59.1%60.7%
Operating margin28.6%32.0%33.6%35.5%
Net margin16.5%15.5%14.5%12.6%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings29.123.130.035.934.531.742.825.229.648.5
Price to sales4.04.54.84.54.04.03.92.42.83.4

Dividends and splits

Per share, in the currency the company pays

Paid for 31 years. Last went ex-dividend on 5 Jun 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2020FY2019
Paid in the year13.0013.0013.008.505.005.006.003.00
  • 5-for-2 split · 24 Apr 2006
  • 5-for-1 split · 12 May 2004
  • 3-for-1 split · 18 Oct 1999

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.